Navigation Links
Triax Pharmaceuticals, Providers of the No. 1 Prescribed Mid-Potentcy Corticosteroid Brand, Introduce a New Size of Locoid Lotion 0.1%
Date:3/19/2009

Launched at the 67th Annual American Academy of Dermatology Meeting

Cranford, NJ (PRWEB) March 19, 2009 -- Atopic dermatitis (AD) is very common in the United States. It affects nearly 15 million people (1% to 3% of adults and 10% to 20% of children).1, and accounts for 10 to 20 percent of all visits to dermatologists. The key symptom is pruritus (itching), leading to the description of AD as "the itch that rashes." Topical corticosteroids have become the cornerstone of treatment for a variety of inflammatory dermatoses, including atopic dermatitis (AD), eczema, and psoriasis.2

Triax Pharmaceuticals, the marketers of Locoid Lipocream® (hydrocortisone butyrate 0.1%) the leading mid-potency corticosteroid brand, introduces a new 4 oz. size of its recently launched Locoid® Lotion.

Launched at the American Academy of Dermatology (AAD) meeting in San Francisco, Locoid® Lotion (hydrocortisone butyrate 0.1%) contains a moisturizing vehicle to cover larger areas and hairy areas of affected skin with an elegant, non-greasy application; and is indicated to treat mild-to-moderate atopic dermatitis in patients as young as 3 months of age2. Locoid Lotion and Locoid Lipocream have been formulated with high concentration of barrier-enhancing lipids. This unique feature provides skin barrier restorative properties for a wide range of patients. Locoid Lotion 0.1% may provide physicians with a formulation that is easier to apply to extensive areas of disease than creams or ointments.

Locoid Lotion (hydrocortisone butyrate 0.1% lotion) is the only class 5 corticosteroid indicated for patients with AD ages 3 months of age and older. It has been proven to provide significant relief of all AD symptoms in pediatric and adult patients2, 3. By the conclusion of one study, 89% of patients had symptoms of skin-barrier disruption eliminated or reduced to mild. By Day
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
2. Biostar Pharmaceuticals, Inc. Completes 8.6-Acre Land Purchase to House New Raw Materials Processing Plant
3. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
4. Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults With Partial Onset Seizures
5. Alseres Pharmaceuticals, Inc. Announces $200,000 Financing
6. Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television
7. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
8. Angiotech Pharmaceuticals, Inc. - Notice of conference call and webcast
9. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
10. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
11. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Triax Pharmaceuticals, Providers of the No. 1 Prescribed Mid-Potentcy Corticosteroid Brand, Introduce a New Size of Locoid Lotion 0.1% 
(Date:9/2/2015)... Los Angeles, CA (PRWEB) , ... September 02, 2015 , ... ... entry featured by the Huffington Post on August 25th, writer Akela Stanfield detailed ... bariatric surgery. While the author acknowledged that she had always seen herself as someone ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... swamped with a large stream of mixed documents that include EOBs, payments, and ... documents, while extracting the data needed to reconcile their billing, with one efficient ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Sciences clinical and academic partnership has earned international recognition as a premier center ... disorder that can cause sudden, catastrophic internal bleeding and stroke. , Cure ...
(Date:9/2/2015)... ... September 02, 2015 , ... Medical ... has completed a recapitalization with new investment partners Beecken Petty O’Keefe & ... each offer extensive expertise and connections within the healthcare industry, which makes ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Amada Senior Care, ... office in Kansas – its Johnson County location. Amada franchise partners Mike ... has a registered nurse background and spent over 20 years in medical device sales ...
Breaking Medicine News(10 mins):Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:Amada Senior Care Expands to Greater Kansas City 2
... Healthcare,Corporation (Nasdaq: UAHC ), which owns and ... organization in,Tennessee, today announced financial results for its ... increased 82 percent to $8.3 million for the ... revenues of $4.6 million for,the third quarter of ...
... MOUNTAIN VIEW, Calif., May 13 IRIDEX,Corporation (Nasdaq: IRIX ... ended March 29, 2008., Revenue for the first quarter ... million reported for the first quarter of 2007. The,Company,s net ... the,first quarter of 2008 compared with a net loss of ...
... for, Potential 2008 Launch of MOXATAG; Keflex Product Sales Total $2.4 ... ... GERMANTOWN, Md., May 13 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ... today,announced financial and operational results for the quarter ended March 31,2008., ...
... that treat the poor from improving, study finds , , TUESDAY, ... hospitals that treat poor and underserved patients, often called safety-net ... these patients, a new study finds. , These hospitals, which ... sources, do not have the money to improve the quality ...
... to treat a rare but well-known genetic disorder may hold ... potentially lethal enlarged hearts, due mainly to high blood pressure, ... common denominator in both phenylketonuria (PKU) and cardiac hypertrophy is ... helps break down the molecule phenylalanine whose buildup is toxic ...
... BLOOMFIELD HILLS, Mich., May 13 CJPS Enterprises, ... be holding a,half-day mini-seminar and interactive discussions about ... to increase their,competitiveness, and therefore their worth. This ... June 6th, 2008 and is applicable to both ...
Cached Medicine News:Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 2Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 3Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 4Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 5Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 6Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 7Health News:IRIDEX Reports First Quarter 2008 Financial Results 2Health News:IRIDEX Reports First Quarter 2008 Financial Results 3Health News:IRIDEX Reports First Quarter 2008 Financial Results 4Health News:IRIDEX Reports First Quarter 2008 Financial Results 5Health News:IRIDEX Reports First Quarter 2008 Financial Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 3Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 4Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 5Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 7Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 8Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 9Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 10Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 11Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 12Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 13Health News:Quality Lags at Safety-Net Hospitals 2Health News:Quality Lags at Safety-Net Hospitals 3Health News:Drug therapy for PKU reverses heart damage 2Health News:Drug therapy for PKU reverses heart damage 3Health News:Drug therapy for PKU reverses heart damage 4Health News:Intellectual Property Buildup Seminar to be Held in Detroit 2
(Date:9/2/2015)... Sept. 2, 2015 The quantum dot market report ... key market based on the product includes medical devices, display, ... sensor, lighting, battery and energy storage, QD laser, and transistor. ... for the quantum dot market. The report also provides the ... America , Europe , ...
(Date:9/2/2015)... 2, 2015 Advanced Wound Dressings - ... Advanced dressings have steadily replaced traditional bandages and ... of wound indications, such as trauma wounds, burns, ... and physical protection become increasingly critical in wound ... standard therapy. This report focuses on nine ...
(Date:9/2/2015)... -- About Chronic Lymphocytic Leukemia Chronic ... production of lymphocytes. It has been observed that the ... to other parts of the body. This leukemia is ... buildup of the cancerous cells. During the course of ... and lymph nodes. The course of the disease is ...
Breaking Medicine Technology:Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 2Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019 3
... BEIJING , April 22 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals,Inc. ... medicine and drugs in the People,s,Republic of China (the "PRC"), today reported ... April 24-26, 2010, Venue: ... Primary Booth: Liang Fang, Beijing Delegate Area, , ...
... April 22 CardioGenics Inc. (OTC Bulletin Board: CGNH), a developer ... market, will be spotlighted in three publications during the month of April: ... The Wall Street Transcript . , ... In the April 2010 print and online editions ...
Cached Medicine Technology:Lotus Pharmaceuticals to Exhibit at the 63rd PHARMCHINA 2CardioGenics to be Spotlighted in Three Publications During Month of April 2CardioGenics to be Spotlighted in Three Publications During Month of April 3CardioGenics to be Spotlighted in Three Publications During Month of April 4
... technology is here! LTF™ (Layered Thin Film) ... test platform that is easy to read, ... as a credit card. What is Infectious ... reason women visit their physician. Vaginal discharge ...
... test! QuickScreen multi-panel dip cards offer minimal ... choice of any conceivable combination of 9 ... for your drug testing program. Just dip ... built-in timer tells you when to read ...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
Medicine Products: